The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Carbisocaine     diethyl-[2-[(2- heptoxyphenyl)carbamoyloxy]...

Synonyms: BK-95, CCRIS 3899, LS-51250, AC1L18RK, 68931-03-3, ...
This record was replaced with 50266.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Carbizocaine


High impact information on Carbizocaine


Biological context of Carbizocaine


Anatomical context of Carbizocaine


Associations of Carbizocaine with other chemical compounds

  • The perturbation effects of lidocaine and Ka-O were found to increase with increasing pH of the sample, whereas the effect of carbisocaine decreased with increasing pH [9].

Gene context of Carbizocaine


Analytical, diagnostic and therapeutic context of Carbizocaine


  1. Pharmacological properties of a new local anaesthetic, carbisocaine. Tumová, I., Svec, P. Drugs under experimental and clinical research. (1986) [Pubmed]
  2. A genotoxicological study of the new local anaesthetic carbamate derivatives carbisocaine, heptacaine and pentacaine. Siekel, P. Journal of applied toxicology : JAT. (1990) [Pubmed]
  3. Determination of carbisocaine, heptacaine and pentacaine in plasma by capillary gas chromatography with nitrogen-selective detection. Marko, V., Wijsbeek, J., De Zeeuw, R.A. Journal of pharmaceutical and biomedical analysis. (1986) [Pubmed]
  4. Perturbation of lipid membranes by local anaesthetic carbisocaine. Ondrias, K., Misík, V., Stolc, S. Drugs under experimental and clinical research. (1986) [Pubmed]
  5. pH dependence of the blocking activity of carbisocaine and its derivatives. Stankovicová, T., Stolc, S., Szöcsová, H., Benes, L. Drugs under experimental and clinical research. (1986) [Pubmed]
  6. Persistent suppression of phagocytosis after prolonged administration of local anesthetics carbisocaine and heptacaine in mouse leukocytes. Vegh, V., Bukovsky, M. Die Pharmazie. (2005) [Pubmed]
  7. Pharmacokinetics of carbisocaine in rats and mice. Bezek, S., Faberová, V., Scasnár, V., Trnovec, T., Durisová, M., Kállay, Z. European journal of drug metabolism and pharmacokinetics. (1988) [Pubmed]
  8. Comparison of the effects of carbisocaine and other local anesthetics on 32P incorporation into individual and total phospholipids in synaptosomes. Horáková, L., Stolc, S. Gen. Physiol. Biophys. (1988) [Pubmed]
  9. pH-dependent effects of local anaesthetics in perturbing lipid membranes. Ondrias, K., Gallová, J., Szöcsová, H., Stolc, S. Gen. Physiol. Biophys. (1987) [Pubmed]
  10. Study of local anesthetics. Part 128. HPLC study of the degradation of heptacaine and carbisocaine in urine, human and rabbit serums. Lehotay, J., Cizmárik, J., Brandsteterová, E. Acta pharmaceutica Hungarica. (1995) [Pubmed]
  11. HPLC separation of enantiomers of carbisocaine. Study of local anaesthetics, part 138. Cizmárik, J., Lehotay, J., Hromul'aková, K., Pokorná, M., Lacuska, M. Die Pharmazie. (1997) [Pubmed]
WikiGenes - Universities